Mural Oncology plc

Rentabilité sur six mois: -44.97%
Rendement en dividendes: 0%

2.46 $

0 $ 0%
0.9952 $
4.47 $

paper.min_max_per_year

Calendrier des promotions Mural Oncology plc

À propos de l'entreprise Mural Oncology plc

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.

Paramètres de base

IPO date
2023-11-16
ISIN
IE000LK2BOB4
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 0 0
P/BV 0.3886 10
P/E 0 0
Efficacité
Nom Signification Grade
ROA -54.55 0
ROE -63.57 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.0642 10
Debt/Ratio 0.0474 10
Debt/Equity 0.2056 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 0 0
Rentabilité Ebitda, % -28.12 0
Rentabilité EPS, % -27.88 0

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 2.46 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 2.56 $ 0 $ 0 $ -3.91 % 0 % 0 %
common.calendar.number_days.30d 2.75 $ 2.46 $ 2.61 $ -10.55 % 0 % 0 %
common.calendar.number_days.90d 1.03 $ 0.9952 $ 2.98 $ 138.83 % 0 % 0 %
common.calendar.number_days.180d 4.47 $ 0.9952 $ 4.47 $ -44.97 % 0 % 0 %
common.calendar.number_days.1y 3.15 $ 0.9952 $ 4.47 $ -21.9 % 0 % 0 %
common.calendar.number_days.3y 0.9952 $ 0.9952 $ 6.01 $ 247.19 % 0 % 0 %
common.calendar.number_days.5y 0.9952 $ 0.9952 $ 6.01 $ 247.19 % 0 % 0 %
common.calendar.number_days.10y 0.9952 $ 0.9952 $ 6.01 $ 247.19 % 0 % 0 %
common.calendar.number_days.ytd 3.66 $ 0.9952 $ 4.47 $ -32.79 % 0 % 0 %

Principaux propriétaires

Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Ms. Caroline J. Loew Ph.D. President, CEO & Director 303.29k 1971 (54 année)
Mr. Adam D. Cutler B.A. CFO, Principal Financial Officer & Principal Accounting Officer 496.65k 1975 (50 années)
Ms. Maiken Keson-Brookes Chief Legal Officer N/A 1973 (52 année)
Mr. Justin Levine Head of Human Resources & VP of Human Resources N/A
Dr. Vicki L. Goodman M.D. Chief Medical Officer 578.34k 1971 (54 année)

Informations sur l'entreprise

Adresse: Ireland, Dublin D T, 10 Earlsfort Terrace - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.muraloncology.com